pharmaceuticals

Aurobindo Pharma Limited Q4 FY22 Earnings Conference Call Insights

● Jun 6, 2022

Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q4 FY22 Earnings Concall Management Update: AUROPHARMA received final approval for 3 ANDAs...

Hikal Limited Q4 FY22 Earnings Conference Call Insights

● Jun 6, 2022

Key highlights from Hikal Limited (HIKAL) Q4 FY22 Earnings Concall Management Update: HIKAL said its new product launches in anti-diabetic...

Glenmark Pharmaceuticals Limited Q4 FY22 Earnings Conference Call Insights

● Jun 2, 2022

Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q4 FY22 Earnings Concall Management Update: GLENMARK said the India business continues to...

Aurobindo Pharma Ltd (AUROPHARMA) Q4 FY22 Earnings Concall Transcript

● Jun 1, 2022

Aurobindo Pharma Ltd (NSE: AUROPHARMA) Q4 FY22 Earnings Concall dated May 30, 2022 Corporate Participants: Deepthi Thakur — Investor Relations Santhanam Subramanian — Chief...

Piramal Enterprises Ltd Q4 FY22 Earnings Conference Call Insights

● Jun 1, 2022

Key highlights from Piramal Enterprises Ltd (PEL) Q4 FY22 Earnings Concall Management Update: Over the next five years, PEL aspire...

Torrent Pharmaceuticals Ltd Q4 FY22 Earnings Conference Call Insights

● May 26, 2022

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY22 Earnings Concall Q&A Highlights: Anubhav Aggarwal of Credit Suisse asked about...

Supriya Lifescience Ltd Q4 FY22 Earnings Conference Call Insights

● May 24, 2022

Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q4 FY22 Earnings Concall Management Update: SUPRIYA said that going forward the company’s...

Divi’s Laboratories Ltd Q4 FY22 Earnings Conference Call Insights

● May 24, 2022

Key highlights from Divi’s Laboratories Ltd (DIVISLAB) Q4 FY22 Earnings Concall Management Update: DIVISLAB said it reached milestone revenue for...

Dr. Reddy’s Laboratories (DRREDDY) Q4 FY22 Earnings Concall Transcript

● May 20, 2022

Dr. Reddy’s Laboratories (NSE: DRREDDY) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Amit Agarwal — Head of Investor Relations...

Gland Pharma Ltd. (GLAND) Q4 FY22 Earnings Concall Transcript

● May 20, 2022

Gland Pharma Ltd. (NSE: GLAND) Q4 FY22 Earnings Concall dated May 19, 2022 Corporate Participants: Sumanta Bajpayee — Vice President-Finance & Investor...